Acetyl-l-carnitine

Acetyl-l-carnitine: New Study - Life Extension Update, Janurary 1995 (in Life Extension Magazine, December 1994) In a new study on 481 geriatric human subjects, the administration of acetyl-L-carnitine produced significant improvement in cognitive function. The authors of the study concluded that acetyl-L-carnitine may be an effective treatment for dementia. We have reprinted the entire abstract of this study on page one of Life Extension Abstracts.

The two most important findings are:

1) The cognitive enhancing and emotional stabilizing effects of acetyl-L-carnitine persisted after its administration was halted. This means that you may not have to take acetyl-L-carnitine all the time to derive benefit from it.

2) Several recognized tests for cognitive function were used and acetyl-L-carnitine consistently produced significant benefits, including improvements in short-term memory and alleviation of depression.

Acetyl-L-carnitine is used in Europe to treat many forms of senile dementia including Alzheimer's disease and cerebral blood flow disorders. It is one of the most well documented cognitive enhancing therapies for people of all ages. Acetyl-L-carnitine is in the FDA approval process, but who knows when it will be available to Americans . . . if ever.

The suggested dose is two capsules a day for healthy people and four capsules a day for those suffering from any type of neurological impairment.

If you cannot afford to use acetyl-L-carnitine on a regular basis, this new study confirms previous studies indicating that using acetyl-L-carnitine for just a few months can provide longer-acting benefits.